|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mooradian AD, Smith M and Tokuda M: The
role of artificial and natural sweeteners in reducing the
consumption of table sugar: A narrative review. Clin Nutr ESPEN.
18:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iga Y, Nakamichi K, Shirai Y and Matsuo T:
Acute and sub-chronic toxicity of D-allose in rats. Biosci
Biotechnol Biochem. 74:1476–1478. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamada T, Iida T, Takamine S, Hayashi N
and Okuma K: Safety evaluation of rare sugar syrup: Single-dose
oral toxicity in rats, reverse mutation assay, chromosome
aberration assay, and acute non-effect level for diarrhea of a
single dose in humans. Shokuhin Eiseigaku Zasshi. 56:211–216.
2015.(In Japanese). View Article : Google Scholar
|
|
6
|
Liu Y, Nakamura T, Toyoshima T, Shinomiya
A, Tamiya T, Tokuda M, Keep RF and Itano T: The effects of D-allose
on transient ischemic neuronal death and analysis of its mechanism.
Brain Res Bull. 109:127–131. 2014. View Article : Google Scholar
|
|
7
|
Yamaguchi F, Takata M, Kamitori K, Nonaka
M, Dong Y, Sui L and Tokuda M: Rare sugar D-allose induces specific
up-regulation of TXNIP and subsequent G1 cell cycle arrest in
hepatocellular carcinoma cells by stabilization of p27kip1. Int J
Oncol. 32:377–385. 2008.
|
|
8
|
Noguchi C, Kamitori K, Hossain A,
Hoshikawa H, Katagi A, Dong Y, Sui L, Tokuda M and Yamaguchi F:
D-allose inhibits cancer cell growth by reducing GLUT1 expression.
Tohoku J Exp Med. 238:131–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hoshikawa H, Mori T and Mori N: In vitro
and in vivo effects of D-allose: Up-regulation of
thioredoxin-interacting protein in head and neck cancer cells. Ann
Otol Rhinol Laryngol. 119:567–571. 2010. View Article : Google Scholar
|
|
10
|
Hoshikawa H, Kamitori K, Indo K, Mori T,
Kamata M, Takahashi T and Tokuda M: Combined treatment with
D-allose, docetaxel and radiation inhibits the tumor growth in an
in vivo model of head and neck cancer. Oncol Lett. 15:3422–3428.
2018.
|
|
11
|
Balamurugan K: HIF-1 at the crossroads of
hypoxia, inflammation, and cancer. Int J Cancer. 138:1058–1066.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rabinowitz JD and White E: Autophagy and
metabolism. Science. 330:1344–1348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Heitman J, Movva NR and Hall MN: Targets
for cell cycle arrest by the immunosuppressant rapamycin in yeast.
Science. 253:905–909. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Noda T and Ohsumi Y: Tor, a
phosphatidylinositol kinase homologue, controls autophagy in yeast.
J Biol Chem. 273:3963–3966. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim J, Kundu M, Viollet B and Guan KL:
AMPK and mTOR regulate autophagy through direct phosphorylation of
Ulk1. Nat Cell Biol. 13:132–141. 2011. View
Article : Google Scholar
|
|
16
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao L, Wang Z, Lu D, Huang J, Liu J and
Hong L: Paeonol induces cytoprotective autophagy via blocking the
Akt/mTOR pathway in ovarian cancer cells. Cell Death Dis.
10:6092019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sui X, Chen R, Wang Z, Huang Z, Kong N,
Zhang M, Han W, Lou F, Yang J, Zhang Q, et al: Autophagy and
chemotherapy resistance: A promising therapeutic target for cancer
treatment. Cell Death Dis. 4:e8382013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chude CI and Amaravadi RK: Targeting
autophagy in cancer: Update on clinical trials and novel
inhibitors. Int J Mol Sci. 18:1272017. View Article : Google Scholar
|
|
20
|
Amaravadi RK, Lippincott-Schwartz J, Yin
XM, Weiss WA, Takebe N, Timmer W, DiPaola RS, Lotze MT and White E:
Principles and current strategies for targeting autophagy for
cancer treatment. Clin Cancer Res. 17:654–666. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nicklin P, Bergman P, Zhang B,
Triantafellow E, Wang H, Nyfeler B, Yang H, Hild M, Kung C, Wilson
C, et al: Bidirectional transport of amino acids regulates mTOR and
autophagy. Cell. 136:521–534. 2009. View Article : Google Scholar
|
|
22
|
Yu L, McPhee CK, Zheng L, Mardones GA,
Rong Y, Peng J, Mi N, Zhao Y, Liu Z, Wan F, et al: Termination of
autophagy and reformation of lysosomes regulated by mTOR. Nature.
465:942–946. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim YC and Guan KL: mTOR: A pharmacologic
target for autophagy regulation. J Clin Invest. 125:25–32. 2015.
View Article : Google Scholar
|
|
24
|
Mrakovcic M and Frohlich LF: p53-mediated
molecular control of autophagy in tumor cells. Biomolecules.
8:142018. View Article : Google Scholar
|
|
25
|
Kim E, Goraksha-Hicks P, Li L, Neufeld TP
and Guan KL: Regulation of TORC1 by Rag GTPases in nutrient
response. Nat Cell Biol. 10:935–945. 2008. View Article : Google Scholar
|
|
26
|
Sancak Y, Bar-Peled L, Zoncu R, Markhard
AL, Nada S and Sabatini DM: Ragulator-Rag complex targets mTORC1 to
the lysosomal surface and is necessary for its activation by amino
acids. Cell. 141:290–303. 2010. View Article : Google Scholar
|
|
27
|
Corcelle E, Djerbi N, Mari M, Nebout M,
Fiorini C, Fenichel P, Hofman P, Poujeol P and Mograbi B: Control
of the autophagy maturation step by the MAPK ERK and p38: Lessons
from environmental carcinogens. Autophagy. 3:57–59. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsui Y, Takagi H, Qu X, Abdellatif M,
Sakoda H, Asano T, Levine B and Sadoshima J: Distinct roles of
autophagy in the heart during ischemia and reperfusion: roles of
AMP-activated protein kinase and Beclin 1 in mediating autophagy.
Circ Res. 100:914–922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jozwiak P, Krzeslak A, Bryś M and Lipinska
A: Glucose-dependent glucose transporter 1 expression and its
impact on viability of thyroid cancer cells. Oncol Rep. 33:913–920.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ao H, Li H, Zhao X, Liu B and Lu L: TXNIP
positively regulates the autophagy and apoptosis in the rat muller
cell of diabetic retinopathy. Life Sci. 267:1189882021. View Article : Google Scholar
|
|
31
|
Zhang X, Cheng D, Liu Y, Wu Y and He Z:
Gephyrin suppresses lung squamous cell carcinoma development by
reducing mTOR pathway activation. Cancer Manag Res. 11:5333–5341.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang Z, Zhang L, Ma A, Liu L, Li J, Gu J
and Liu Y: Transient mTOR inhibition facilitates continuous growth
of liver tumors by modulating the maintenance of CD133+ cell
populations. PLoS One. 6:e284052011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kenerson HL, Aicher LD, True LD and Yeung
RS: Activated mammalian target of rapamycin pathway in the
pathogenesis of tuberous sclerosis complex renal tumors. Cancer
Res. 62:5645–5650. 2002.PubMed/NCBI
|
|
34
|
Inoki K, Corradetti MN and Guan KL:
Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet.
37:19–24. 2005. View
Article : Google Scholar
|
|
35
|
Nazio F, Bordi M, Cianfanelli V, Locatelli
F and Cecconi F: Autophagy and cancer stem cells: Molecular
mechanisms and therapeutic applications. Cell Death Differ.
26:690–702. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Han W, Pan H, Chen Y, Sun J, Wang Y, Li J,
Ge W, Feng L, Lin X, Wang X, et al: EGFR tyrosine kinase inhibitors
activate autophagy as a cytoprotective response in human lung
cancer cells. PLoS One. 6:e186912011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen K and Shi W: Autophagy regulates
resistance of non-small cell lung cancer cells to paclitaxel.
Tumour Biol. 37:10539–10544. 2016. View Article : Google Scholar
|
|
38
|
Ojha R, Bhattacharyya S and Singh SK:
Autophagy in cancer stem cells: A potential link between
chemoresistance, recurrence, and metastasis. Biores Open Access.
4:97–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chi KH, Ko HL, Yang KL, Lee CY, Chi MS and
Kao SJ: Addition of rapamycin and hydroxychloroquine to metronomic
chemotherapy as a second line treatment results in high salvage
rates for refractory metastatic solid tumors: A pilot safety and
effectiveness analysis in a small patient cohort. Oncotarget.
6:16735–16745. 2015. View Article : Google Scholar
|
|
40
|
Kimura T, Takabatake Y, Takahashi A and
Isaka Y: Chloroquine in cancer therapy: A double-edged sword of
autophagy. Cancer Res. 73:3–7. 2013. View Article : Google Scholar : PubMed/NCBI
|
